Picture of TOWA PHARMACEUTICAL logo

4553 — TOWA PHARMACEUTICAL News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedMid CapNeutral

Table: Towa Pharmaceutical - 9-MTH group results

Feb 13 (Reuters)-  
             Towa Pharmaceutical Co Ltd  
             CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                   9 months ended      9 months ended       Year to  
                  Dec 31, 2017        Dec 31, 2016     Mar 31, 2018  
                     LATEST             YEAR-AGO          LATEST     
                     RESULTS             RESULTS         FORECAST    
  Sales               70.41               63.70            94.00     
                   (+10.5 pct)         (+4.0 pct)       (+10.7 pct)  
  Operating            9.21                5.51            11.80     
                   (+67.2 pct)         (-38.3 pct)      (+71.8 pct)  
  Recurring           10.47                6.50            12.00     
                   (+61.2 pct)         (-27.2 pct)      (+61.8 pct)  
  Net                  7.37                4.80             8.40     
                   (+53.5 pct)         (-23.8 pct)      (+50.6 pct)  
  EPS              449.52 yen          292.92 yen       512.10 yen   
  EPS Diluted      415.74 yen          270.80 yen                    
  Ann Div                               95.00 yen        95.00 yen   
  -Q2 div           47.50 yen           47.50 yen                    
  -Q4 div                               47.50 yen        47.50 yen   
   
  NOTE - Towa Pharmaceutical Co Ltd.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4553.T 
  ((Tokyo Headline News Desk +813 6441 1812))

Recent news on TOWA PHARMACEUTICAL

See all news